Oppenheimer & Co’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-13,500
| Closed | -$55K | – | 1552 |
|
|
2021
Q2 | $55K | Sell |
13,500
-1,000
| -7% | -$3.92K | ﹤0.01% | 1484 |
|
|
2021
Q1 | $62K | Buy |
14,500
+2,000
| +16% | +$9.55K | ﹤0.01% | 1415 |
|
|
2020
Q4 | $49K | Sell |
12,500
-23,500
| -65% | -$98.1K | ﹤0.01% | 1329 |
|
|
2020
Q3 | $133K | Buy |
36,000
+18,600
| +107% | +$78.5K | ﹤0.01% | 1210 |
|
|
2020
Q2 | $59K | Sell |
17,400
-300
| -2% | -$672 | ﹤0.01% | 1230 |
|
|
2020
Q1 | $24K | Buy |
17,700
+7,000
| +65% | +$11K | ﹤0.01% | 1174 |
|
|
2019
Q4 | $16K | Buy |
10,700
+486
| +5% | +$814 | ﹤0.01% | 1268 |
|
|
2019
Q3 | $21K | Sell |
10,214
-1,500
| -13% | -$3.06K | ﹤0.01% | 1245 |
|
|
2019
Q2 | $29K | Sell |
11,714
-600
| -5% | -$1.31K | ﹤0.01% | 1288 |
|
|
2019
Q1 | $32K | Sell |
12,314
-1,200
| -9% | -$3.63K | ﹤0.01% | 1331 |
|
|
2018
Q4 | $41K | Sell |
13,514
-2,500
| -16% | -$8.48K | ﹤0.01% | 1214 |
|
|
2018
Q3 | $55K | Sell |
16,014
-1,300
| -8% | -$6.9K | ﹤0.01% | 1324 |
|
|
2018
Q2 | $81K | Sell |
17,314
-1,500
| -8% | -$5.69K | ﹤0.01% | 1296 |
|
|
2018
Q1 | $60K | Buy |
18,814
+3,150
| +20% | +$12.7K | ﹤0.01% | 1304 |
|
|
2017
Q4 | $77K | Sell |
15,664
-29,915
| -66% | -$174K | ﹤0.01% | 1282 |
|
|
2017
Q3 | $313K | Sell |
45,579
-8,529
| -16% | -$53.8K | 0.01% | 1019 |
|
|
2017
Q2 | $356K | Sell |
54,108
-12,293
| -19% | -$86.2K | 0.01% | 960 |
|
|
2017
Q1 | $531K | Buy |
66,401
+25,413
| +62% | +$214K | 0.02% | 775 |
|
|
2016
Q4 | $381K | Buy |
40,988
+12,673
| +45% | +$131K | 0.01% | 903 |
|
|
2016
Q3 | $300K | Buy |
28,315
+1,964
| +7% | +$19.6K | 0.01% | 989 |
|
|
2016
Q2 | $246K | Sell |
26,351
-3,760
| -12% | -$38.2K | 0.01% | 1033 |
|
|
2016
Q1 | $313K | Buy |
30,111
+3,366
| +13% | +$30.8K | 0.01% | 919 |
|
|
2015
Q4 | $268K | Buy |
+26,745
| New | +$268K | 0.01% | 998 |
|
|
2015
Q2 | – | Sell |
-36,317
| Closed | -$514K | – | 1528 |
|
|
2015
Q1 | $514K | Sell |
36,317
-19,936
| -35% | -$259K | 0.01% | 855 |
|
|
2014
Q4 | $562K | Sell |
56,253
-14,398
| -20% | -$123K | 0.02% | 777 |
|
|
2014
Q3 | $600K | Buy |
70,651
+16,194
| +30% | +$142K | 0.02% | 782 |
|
|
2014
Q2 | $481K | Buy |
54,457
+18,402
| +51% | +$161K | 0.01% | 867 |
|
|
2014
Q1 | $335K | Sell |
36,055
-156,886
| -81% | -$1.38M | 0.01% | 997 |
|
|
2013
Q4 | $1.63M | Buy |
192,941
+175,712
| +1,020% | +$1.78M | 0.05% | 400 |
|
|
2013
Q3 | $151K | Sell |
17,229
-5,650
| -25% | -$45.3K | 0.01% | 1206 |
|
|
2013
Q2 | $162K | Buy |
+22,879
| New | +$158K | 0.01% | 1147 |
|
Other funds holding OPK
OIM
Oppenheimer & Co's OPK Position: Q3 2021 in Review
Oppenheimer & Co sold out of Opko Health (OPK) in Q3 2021, closing a stake of 13,500 shares — an estimated $55K sold.
Oppenheimer & Co first reported a position in OPK in Q2 2013 and held it in 31 quarters. The position peaked at $1.63M in Q4 2013. 206 funds tracked by Wall St. Rank hold OPK as of Q3 2021.
- Oppenheimer & Co reported no remaining Opko Health position as of Q3 2021 after selling out during the quarter.
- Oppenheimer & Co sold 13,500 Opko Health shares in Q3 2021, an estimated $55K.
- Oppenheimer & Co first reported a position in Opko Health in Q2 2013 and held it in 31 quarters.
- Oppenheimer & Co's Opko Health position peaked at $1.63M in Q4 2013.
- 206 funds tracked by Wall St. Rank held Opko Health as of Q3 2021.
Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.